Nature Research

SHERPA: Unknown

People

  1. Reuter
    Reuter
  2. Ladanyi
    Ladanyi
  3. Al-Ahmadie
    Al-Ahmadie
  4. Fine
    Fine
  5. Tickoo
    Tickoo
  6. Gopalan
    Gopalan
  7. Antonescu
    Antonescu
  8. Shia
    Shia
  9. Chen
    Chen
  10. Travis
    Travis

Groups

  1. Department of Pathology and Laboratory Medicine (1457)
  2. GSK Faculty (537)
  3. Surgery (392)
  4. GDMT, Pathology and Laboratory Medicine (355)
  5. Gynecology Disease Management Team (355)
  6. Department of Medicine (344)
  7. Tow Center for Developmental Oncology (TCDO) (323)
  8. Human Oncology and Pathogenesis Program (312)
  9. Solid Tumor Oncology Division (265)
  10. Sloan Kettering Institute Postdocs (230)
Search Within
Formats
  1. Meeting Abstract (1494)
  2. Journal Article (347)
  3. Editorial (18)
  4. Review (16)
  5. Correspondence (2)
  6. Guidelines (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1457)
  2. GSK Faculty (537)
  3. Surgery (392)
  4. GDMT, Pathology and Laboratory Medicine (355)
  5. Gynecology Disease Management Team (355)
  6. Department of Medicine (344)

More Groups

People
  1. Victor Reuter (256)
  2. David Klimstra (218)
  3. Robert Soslow (197)
  4. Marc Ladanyi (191)
  5. Hikmat Al-Ahmadie (164)
  6. Samson Fine (159)

More People

Years
  1. 2025 (15)
  2. 2024 (28)
  3. 2023 (32)
  4. 2022 (118)
  5. 2021 (93)
  6. 2020 (64)

More Years

Publications
  1. Modern Pathology (1812)
  2. Nature Cancer (66)

Results (1878)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive next-generation sequencing reliably distinguishes primary squamous cell carcinoma of the lung from metastatic lung tumors of head and neck origin
    Meeting Abstract

    Elsayad, M.; Febres-Aldana, C.; Ghossein, R.; Travis, W.; Rekhtman, N.; Chang, J.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • The initial pathological diagnosis of ganglioneuroblastoma, intermixed, at presentation: The clinicopathological implications
    Meeting Abstract

    Nezami, B.; Alghamdi, M.; Cardenas, F.; Sarungbam, J.; Sirintrapun, S. J.; Gopalan, A.; Chen, Y. B.; Al-Ahmadie, H.; Reuter, V.; Modak, S.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • PD-L1/PD-1 proximity assay: Witnessing the real protein-protein interaction
    Meeting Abstract

    Kombak, F. E.; Bhanot, U.; Tanaka, A.; Ondrejkovic, K.; Linkov, I.; Asher, M.; Murillo, A.; Silber, J.; Roehrl, M.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Simultaneous bright field chromogenic multiplex immunohistochemistry with HRP-based new chromogens: A better and more precise way of PD-L1 scoring with added benefits
    Meeting Abstract

    Kombak, F. E.; Bhanot, U.; Tanaka, A.; Ondrejkovic, K.; Linkov, I.; Asher, M.; Murillo, A.; Silber, J.; Roehrl, M.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Unexpected histologic and molecular features in tumors of long-term survivors (LTS) of diffuse pleural mesothelioma (DPM)
    Meeting Abstract

    Baine, M.; Adusumilli, P.; Bodd, F.; Ladanyi, M.; Offin, M.; Travis, W.; Yang, S. R.; Ventura, K.; Zauderer, M.; Sauter, J.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Standardization of pathologic sampling and evaluation of gallbladder specimens: Recommendations of the International Study Group On Gallbladder Cancer (ISG-GBC) of International Hepato-Pancreato-Biliary Association (IHPBA)
    Meeting Abstract

    Adsay, N. V.; Basturk, O.; Roa, J. C.; Memis, B.; Pehlivanoglu, B.; Jang, K.; Araya, J.; Jang, J. Y.; Lee, K.; Reid, M.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Centrally-necrotic/hyalinizing demarcated (CND) carcinomas of the pancreas: A clinico-pathologically distinct group with divergent metaplastic patterns and high-grade characteristics
    Meeting Abstract

    Cengiz, D.; Saka, B.; Bagci, P.; Altinmakas, E.; Bozkurt, E.; Armutlu, A.; Pehlivanoglu, B.; Bozkurtlar, E.; Reid, M.; Mericoz, M. A.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Ki67 of >=10% identifies an aggressive group of panNETS and lends support to emerging protocols in oncology literature utilizing this cut-off for closer follow-up and chemotherapy candidates
    Meeting Abstract

    Eren, O.; Bagci, P.; Balci, S.; Saka, B.; Sokmensuer, C.; Leblebici, C. B.; Xue, Y.; Reid, M.; Taskin, O.; Kapran, Y.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Patterns of intraparenchymal spread of pancreatic ductal adenocarcinoma within whipple specimens, and their clinical significance: Importance of focused lymph node examination, and sampling of the anterior surfaces
    Meeting Abstract

    Saka, B.; Balci, S.; Pehlivanoglu, B.; Bagci, P.; Memis, B.; Reid, M.; Basturk, O.; Adsay, N. V.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Basophilia predicts poorer outcomes in BCR-ABL1-negative myeloproliferative neoplasms
    Meeting Abstract

    Yuen, L.; Gogakos, T.; Boiocchi, L.; Hobbs, G.; Hasserjian, R.
    Modern Pathology (2022)

    Fulltext@MSK | Save

    • Nature Research – authorized name for: